( OTC-BB:OPLI,OTC-PINK:CANFY,TelAviv:CFBI )

News from Can-Fite BioPharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 06, 2014, 07:00 ET ‏Can-Fite Submitted Phase II Study Protocol with CF102 to Treat Patients with Advanced Liver Cancer

 Can-Fite BioPharma (TASE: CFBI), (OTC: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address...


Dec 11, 2013, 07:00 ET Can-Fite CEO Issues Letter to Shareholders

 Can-Fite BioPharma (NYSE MKT: CANF), (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...


Dec 02, 2013, 07:00 ET Can-Fite CEO to Ring Opening Bell at New York Stock Exchange

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF), (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...


Nov 20, 2013, 07:00 ET Can-Fite BioPharma Generates Partnership Interest at Therapeutic Area Partnerships Conference in Boston

 Can-Fite BioPharma (NYSE MKT: CANF), (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...


Nov 11, 2013, 07:00 ET Can-Fite BioPharma to Conduct U.S. Road Show on November 18 - 21, 2013

 On the heels of its European road show, Can-Fite BioPharma (TASE: CFBI), (OTCQB: CANFY), a biotechnology company with a pipeline of...


Nov 05, 2013, 07:00 ET Can-Fite BioPharma to Conduct European Road Show

 Can-Fite BioPharma (TASE: CFBI), (OTCQB: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address...


Feb 05, 2013, 09:52 ET Can-Fite Announces Successful Completion of its Public Offering

Can-Fite BioPharma (TASE: CFBI; OTC: CANFY) a biotechnology company with a pipeline of proprietary small molecule drugs that address...


Nov 13, 2012, 10:00 ET Can-Fite BioPharma to Develop a Drug for the Treatment of Sexual Dysfunction

Can-Fite BioPharma (TASE: CFBI, OTC: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory...


Nov 05, 2012, 08:59 ET Can-Fite BioPharma Receives Quotation Clearance for Its Level 1 ADRs

 Can-Fite BioPharma (TASE: CFBI, OTC: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address...


Oct 09, 2012, 10:46 ET Interim Analysis Supports Continuation of Can-Fite's Phase 2/3 Psoriasis Clinical Study with CF101

 Can-Fite BioPharma (TASE: CFBI; OTC: CANFY) announced today the continuation of patient enrollment in its Psoriasis Phase 2/3 clinical study...


Oct 04, 2012, 08:00 ET Can-Fite BioPharma Begins Trading in U.S. through Launch of ADRs

 Can-Fite BioPharma (TASE: CFBI, OTC: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address...